Suppr超能文献

精神分裂症患者共病的检测与管理。

Detection and management of comorbidity in patients with schizophrenia.

作者信息

Green Alan I, Canuso Carla M, Brenner Mark J, Wojcik Joanne D

机构信息

Department of Psychiatry, Harvard Medical School, Commonwealth Research Center, Massachusetts Mental Health Center, 74 Fenwood Road, Boston, MA 02115, USA.

出版信息

Psychiatr Clin North Am. 2003 Mar;26(1):115-39. doi: 10.1016/s0193-953x(02)00014-x.

Abstract

Approximately half of patients with schizophrenia have at least one comorbid psychiatric or medical condition, worsening prognosis and contributing to the high rate of morbidity and mortality. Depression is associated with suicide, the leading cause of premature death in patients with schizophrenia; obsessive-compulsive symptoms may worsen prognosis; alcohol and substance use disorders are associated with a poor outcome; and comorbid medical conditions, including cardiac and pulmonary disease, infectious diseases, diabetes, hyperlipidemia, hypogonadism, and osteoporosis, are often underrecognized and undertreated. The new generation of antipsychotic medications has improved the potential outcome of patients with schizophrenia. Providing optimal treatment for patients and fully realizing the potential of these new agents require focused attention on detection, recognition, and treatment of comorbid psychiatric and medical conditions in patients with schizophrenia.

摘要

大约一半的精神分裂症患者至少有一种共病的精神或躯体疾病,这会使预后恶化,并导致高发病率和死亡率。抑郁症与自杀有关,自杀是精神分裂症患者过早死亡的主要原因;强迫症状可能会使预后恶化;酒精和物质使用障碍与不良结局有关;共病的躯体疾病,包括心脏和肺部疾病、传染病、糖尿病、高脂血症、性腺功能减退和骨质疏松症,往往未得到充分认识和治疗。新一代抗精神病药物改善了精神分裂症患者的潜在结局。为患者提供最佳治疗并充分发挥这些新药的潜力,需要重点关注精神分裂症患者共病的精神和躯体疾病的检测、识别及治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验